Telomir Pharmaceuticals, Inc.
TELO
$1.22
$0.032.52%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
8/26/2026
-
MarketBeat
8/13/2026
-
The Cerbat Gem
8/13/2026
-
MarketBeat
8/12/2026
-
MarketBeat
7/21/2026
-
MarketBeat
6/15/2026
-
TipRanks: TheFly
6/15/2026
-
ACCESS Newswire
6/8/2026
-
TipRanks
5/20/2026
-
TipRanks Financial Blog
5/20/2026
-
ACCESS Newswire
5/14/2026
-
The Cerbat Gem
4/30/2026
-
ACCESS Newswire
4/30/2026
-
Benzinga
4/24/2026
-
TipRanks Financial Blog
4/24/2026
-
ACCESS Newswire
4/1/2026
-
Pharmaceutical Business Review
3/31/2026
-
TipRanks Financial Blog
3/31/2026
-
TipRanks Financial Blog
3/31/2026
-
TipRanks Financial Blog
3/31/2026
-
The Fly
3/31/2026
-
ACCESS Newswire
3/27/2026
-
TipRanks Financial Blog
3/20/2026
-
Ticker Report
3/17/2026
-
Zolmax
2/17/2026
-
The Fly
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 13, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
786 396 6723
Address
100 SE 2nd Street
Suite 2000 #1009
Miami, FL 33131
Suite 2000 #1009
Miami, FL 33131
Country
Year Founded
Business Description
Sector
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and...
more